Subtotal $0.00
SIRO PMS 2025 Summary
Post-Market Surveillance SIRO 2025 Annual Review A review of safety, quality, manufacturing progress, and customer feedback. InSitu Technologies completed its 2025 post-market surveillance review for the SIRO Drug-Eluting Coronary Stent. The findings confirmed continued product safety,
READ MORE